About HTG Molecular Diagnostics:
Headquartered in Tucson, Arizona, HTG is focused on advancing precision medicine. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Additional information is available at www.htgmolecular.com.
Headquartered in Tucson, Arizona, HTG is focused on advancing precision medicine. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Additional information is available at www.htgmolecular.com.
Location: United States, Arizona, Tucson
Employees: 51-200
Total raised: $500K
Founded date: 1997
Investors 3
| Date | Name | Website |
| - | Autonomy V... | autonomyve... |
| - | Emerging T... | etpvc.com |
| - | Solstice C... | solcap.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.06.2011 | - | $500K | SR One |
Mentions in press and media 8
| Date | Title | Description |
| 03.04.2023 | MarketsandMarkets Hosts Highly Anticipated Its Inaugural Biomarker and Companion Diagnostics Conference - Boston, USA | MarketsandMarkets Biomarker and Companion Diagnostics Conference-East Coast Edition The Expert Panel will take you through their presentations which will include problems, solutions and services in the Clinical Applications of Biomarkers BO... |
| 31.03.2023 | TATAA Biocenter expands its bioanalytical services with HTG certification | TATAA Biocenter expands its bioanalytical services with HTG certification Fri, Mar 31, 2023 14:12 CET Report this content TATAA Biocenter, a leading provider of high-quality molecular analysis services, announced today that it has become a ... |
| 23.12.2022 | HTG Molecular Diagnostics Announces Closing of a $10 Million Public Offering | TUCSON, Ariz., Dec. 23, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. HTGM (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology... |
| 23.12.2022 | HTG Molecular Diagnostics Announces Closing of a $10 Million Public Offering | /EIN News/ -- TUCSON, Ariz., Dec. 23, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medici... |
| 23.12.2022 | HTG Molecular Diagnostics Announces Closing of a $10 Million Public Offering | - |
| 21.12.2022 | HTG Molecular Diagnostics Announces Pricing of a $10 Million Public Offering | - |
| 13.06.2011 | HTG Molecular Diagnostics Receives $500k from SR One in Series D Financing | HTG Molecular Diagnostics, a Tucson, Arizona-based provider of molecular technology solutions, has received a $500k investment from SR One, the corporate venture capital arm of GlaxoSmithKline, in the second tranche of its series D financin... |
| 26.03.2011 | AssureRx drums up $11 million | Funding roundup | Personalized medicine test maker AssureRx Health completed an $11 million Series B round. The Mason, Ohio-based company plans to use the funding to expand sales and marketing for its GeneSightRx test, which helps doctors pick the right psyc... |